Pharma Industry News

Lilly’s antibodies bamlanivimab and etesevimab show promise against COVID-19

Neutralising antibodies significantly reduced COVID-19-related hospitalisations and deathsOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]